• In the media
  • Johnson & Johnson and GSK leaders in antibiot...
Media - published on 23 Jan 2018

Johnson & Johnson and GSK leaders in antibiotics research – report

Pharmaphorum reports on the leaders of the AMR Benchmark and the call for further action to combat the rise of drug-resistant bacteria.

This article covers the results of the AMR Benchmark and the number of antibiotics in the R&D pipeline. “The Netherlands-based Access to Medicine Foundation uncovered the fact that the number of antibiotics in development since 2000 has fallen.”


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |